Guardion Health Sciences, Inc.
GHSI · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $73 | $3,000 | $2,936 | $3,337 |
| % Growth | -97.6% | 2.2% | -12% | – |
| Cost of Goods Sold | $37 | $1,821 | $1,591 | $1,877 |
| Gross Profit | $36 | $1,179 | $1,345 | $1,460 |
| % Margin | 49.8% | 39.3% | 45.8% | 43.8% |
| R&D Expenses | $0 | $3 | $0 | $11 |
| G&A Expenses | $1,396 | $1,835 | $1,670 | $1,904 |
| SG&A Expenses | $1,404 | $2,197 | $2,037 | $2,222 |
| Sales & Mktg Exp. | $8 | $362 | $372 | $319 |
| Other Operating Expenses | $14 | $0 | $0 | $0 |
| Operating Expenses | $1,418 | $2,200 | $2,037 | $2,233 |
| Operating Income | -$1,381 | -$1,021 | -$692 | -$773 |
| % Margin | -1,894.4% | -34% | -23.6% | -23.2% |
| Other Income/Exp. Net | -$752 | -$3,345 | $1,511 | $1,146 |
| Pre-Tax Income | -$2,133 | -$4,747 | $425 | $373 |
| Tax Expense | $0 | $0 | $2,983 | $0 |
| Net Income | $10,324 | -$4,747 | $425 | $373 |
| % Margin | 14,158.8% | -158.2% | 14.5% | 11.2% |
| EPS | 8.04 | -3.71 | 0.33 | 0.29 |
| % Growth | 316.7% | -1,224.2% | 13.8% | – |
| EPS Diluted | 8.04 | -3.71 | 0.33 | 0.29 |
| Weighted Avg Shares Out | 1,284 | 1,280 | 1,275 | 1,273 |
| Weighted Avg Shares Out Dil | 1,284 | 1,280 | 1,275 | 1,273 |
| Supplemental Information | – | – | – | – |
| Interest Income | $117 | $76 | $90 | $95 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $5 | $5 | $5 | $5 |
| EBITDA | -$1,363 | -$1,393 | -$687 | -$768 |
| % Margin | -1,869.1% | -46.4% | -23.4% | -23% |